- Will anyone chase down Musetti in chase for Nitto ATP Finals spot? ATP Tour
- ATP Race: This is how the race to Turin stands with three weeks to go Punto de Break
- Rising stars to watch at the 2025 Nitto ATP Finals Love Tennis Blog
- This is how the…
Blog
-
Will anyone chase down Musetti in chase for Nitto ATP Finals spot? – ATP Tour
-
League of Legends Brings Back Fan-favourite Map
Riot Games continues to honour their past by doing right by all the things that used to make League of Legends cool. From videos that are more stylised to listening to community feedback, it’s been a bit…
Continue Reading
-
Your motherboard might be overvolting your CPU and damaging it, here’s how to check
Even the most seasoned PC builders can fall into the trap of believing that their CPU’s BIOS defaults are safe, sensible, and tuned for stability. After all, out-of-the-box settings provided by motherboard manufacturers must be subject to…
Continue Reading
-
Getafe vs. Real Madrid and all top-flight matches stop for 15 seconds in protest against the LaLiga match in Miami
The Getafe and Real Madrid players held a 15-second pause at the start of the match played at the Coliseum stadium. They joined the initiative, organised by the Spanish Footballers’ Association (AFE) and which took place in all the Primera…
Continue Reading
-
New twist boosts immunotherapy treatment in cancer patients
A new study explains why many tumors ignore immune boosting treatments. It points to a missing gene called MTAP and suggests that an older drug, DFMO, can switch a silenced alarm back on.
This STING (Stimulator of Interferon Genes) pathway is part…
Continue Reading
-
‘Priceless’ jewels stolen from France’s Louvre Museum in four-minute heist | Crime News
The world’s most-visited museum will remain closed for the day for ‘exceptional reasons’.
Thieves wielding power tools have struck at the famed Louvre Museum in Paris, stealing eight items of priceless jewellery in a brazen heist that took…
Continue Reading
-
ESMO 2025: CELC-G-201: Phase 1/2 Study of Gedatolisib in Combination with Darolutamide in mCRPC – UroToday
- ESMO 2025: CELC-G-201: Phase 1/2 Study of Gedatolisib in Combination with Darolutamide in mCRPC UroToday
- Celcuity Presents Updated Data at the 2025 ESMO Congress from Phase 1 Study Evaluating Gedatolisib Plus Darolutamide in Men with Metastatic Castration Resistant Prostate Cancer (“mCRPC”) Yahoo Finance
- Celcuity Inc. Reports Promising Phase 1 Clinical Trial Results for Gedatolisib Combined with Nubeqa® in Advanced Prostate Cancer Quiver Quantitative
- Celcuity Inc. Presents Updated Data At the 2025 Esmo Congress from Phase 1 Study Evaluating Gedatolisib Plus Darolutamide in Men with Metastatic Castration Resistant Prostate Cancer MarketScreener
- Celcuity reports positive Phase 1 data for prostate cancer therapy Investing.com
Continue Reading
-
Nearly 50 miniature bots fight at UK championship event
The robots, each weighing 3.3 pounds or less, went head-to-head at the UK Beetle Championship held at St Michael’s Centre in Stoke Gifford, Bristol.
The event was organized by the Bristol Bot Builders, a group dedicated to sparking…
Continue Reading
-
Cancel the monthly cloud bill and own 1TB forever with Koofr for $130
Tired of living in the land of auto-renew? Same—because even something as basic as watching a movie often starts with logging into Netflix, Max, or whatever subscription you added last month.
If you’re tired of the ever-growing amount of…
Continue Reading
-
Enzalutamide/Leuprolide Regimen Reduces Risk of Death in Prostate Cancer
Enzalutamide (Xtandi) plus leuprolide acetate exhibited a 40.3% lower risk of death compared with leuprolide acetate alone in patients with high-risk, biochemically recurrent prostate cancer, according to findings from the final overall analysis…
Continue Reading